deoxyglucose has been researched along with Allergic Encephalomyelitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, ME; Bin, R; Cerghet, M; Datta, I; Giri, S; Hoda, MN; Kumar, A; Mangalam, AK; Poisson, LM; Rashid, F; Rattan, R; Singh, J; Suhail, H; Waters, J; Zahoor, I | 1 |
1 other study(ies) available for deoxyglucose and Allergic Encephalomyelitis
Article | Year |
---|---|
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target.
Topics: Animals; Anti-Inflammatory Agents; Antimetabolites; Deoxyglucose; Drug Development; Encephalomyelitis, Autoimmune, Experimental; Glycolysis; Humans; Leukocytes, Mononuclear; Metabolomics; Mice; Multiple Sclerosis, Relapsing-Remitting | 2022 |